糖尿病管理機器の世界市場2024~2028

◆英語タイトル:Global Diabetes Management Devices Market 2024-2028

Technavioが発行した調査報告書(IRTNTR70599-24)◆商品コード:IRTNTR70599-24
◆発行会社(リサーチ会社):Technavio
◆発行日:2024年1月
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア太平洋、その他地域
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥380,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥608,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

糖尿病管理機器の世界市場 2024-2028
糖尿病管理機器市場は、2023-2028年に139億8000万米ドルで成長し、予測期間中のCAGRは7.68%で加速すると予測されます。当レポートでは、糖尿病管理機器市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析を掲載しています。

現在の市場シナリオ、最新動向と促進要因、全体的な市場環境に関する最新分析を提供しています。市場は、世界的な糖尿病負担の増加、高度なインスリン送達デバイスに対する需要の高まり、新製品の発売によって牽引されています。

Technavio社の糖尿病管理機器市場は以下のように分類されます:

製品別
• 血糖モニタリング機器
• インスリン送達システム

流通チャネル別
• オフライン
• オンライン

地域別
• 北米
• ヨーロッパ
• アジア
• その他の地域(ROW)

本調査では、人工膵臓への注目の高まりが、今後数年間の糖尿病管理機器市場の成長を牽引する主要因の1つであると特定しています。また、在宅医療への注目の高まりと医療分野の技術進歩は、市場の大きな需要につながります。

本レポートでは、糖尿病管理機器市場について以下の領域をカバーしています:
• 糖尿病管理機器市場のサイジング
• 糖尿病管理機器市場予測
• 糖尿病管理機器市場の産業分析

本レポートでは、糖尿病管理機器市場の主要ベンダーは、Abbott Laboratories、ACON Laboratories Inc.、B.Braun SE、Becton Dickinson and Co、 Bionime Corp.、Dexcom Inc.、Eli Lilly and Co.、F. Hoffmann La Roche Ltd.、iHealth Labs Inc.、Insulet Corp.、LifeScan IP Holdings LLC、Medtronic Plc、Nemaura Medical Inc.、Nipro Corp.、Nova Biomedical Corp.、Novo Nordisk AS、PHC Holdings Corp.、Prodigy Diabetes Care LL、Tandem Diabetes Care Inc.、WellDoc Inc.などの企業が含まれています。また、糖尿病管理機器市場の分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、包括的な市場とベンダーの状況、主要ベンダーの分析が含まれています。

当出版社は、利益、価格、競争、プロモーションなどの主要パラメータの分析を通じて、複数の情報源からのデータを調査、統合、総括することにより、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 糖尿病管理機器の世界市場:製品別
7 糖尿病管理機器の世界市場:流通チャネル別
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global diabetes management devices market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global diabetes management devices market 2018 – 2022 ($ billion)
o 4.2 Product Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
o 4.3 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Product – Market share 2023-2028 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Blood glucose monitoring devices – Market size and forecast 2023-2028
o Exhibit 34: Chart on Blood glucose monitoring devices – Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Blood glucose monitoring devices – Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Blood glucose monitoring devices – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Blood glucose monitoring devices – Year-over-year growth 2023-2028 (%)
o 6.4 Insulin delivery systems – Market size and forecast 2023-2028
o Exhibit 38: Chart on Insulin delivery systems – Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Insulin delivery systems – Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Insulin delivery systems – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Insulin delivery systems – Year-over-year growth 2023-2028 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
o Exhibit 43: Data Table on Market opportunity by Product ($ billion)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 44: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 45: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 46: Chart on Comparison by Distribution Channel
o Exhibit 47: Data Table on Comparison by Distribution Channel
o 7.3 Offline – Market size and forecast 2023-2028
o Exhibit 48: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 49: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
o Exhibit 50: Chart on Offline – Year-over-year growth 2023-2028 (%)
o Exhibit 51: Data Table on Offline – Year-over-year growth 2023-2028 (%)
o 7.4 Online – Market size and forecast 2023-2028
o Exhibit 52: Chart on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Online – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Online – Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Distribution Channel
o Exhibit 56: Market opportunity by Distribution Channel ($ billion)
o Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 63: Chart on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 64: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
o Exhibit 65: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 67: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 79: Chart on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Germany – Market size and forecast 2023-2028
o Exhibit 83: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.9 China – Market size and forecast 2023-2028
o Exhibit 87: Chart on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on China – Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.10 France – Market size and forecast 2023-2028
o Exhibit 91: Chart on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on France – Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on France – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on France – Year-over-year growth 2023-2028 (%)
o 9.11 UK – Market size and forecast 2023-2028
o Exhibit 95: Chart on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 12.4 B.Braun SE
o Exhibit 112: B.Braun SE – Overview
o Exhibit 113: B.Braun SE – Business segments
o Exhibit 114: B.Braun SE – Key news
o Exhibit 115: B.Braun SE – Key offerings
o Exhibit 116: B.Braun SE – Segment focus
o 12.5 Becton Dickinson and Co.
o Exhibit 117: Becton Dickinson and Co. – Overview
o Exhibit 118: Becton Dickinson and Co. – Business segments
o Exhibit 119: Becton Dickinson and Co. – Key news
o Exhibit 120: Becton Dickinson and Co. – Key offerings
o Exhibit 121: Becton Dickinson and Co. – Segment focus
o 12.6 Bionime Corp.
o Exhibit 122: Bionime Corp. – Overview
o Exhibit 123: Bionime Corp. – Product / Service
o Exhibit 124: Bionime Corp. – Key offerings
o 12.7 Eli Lilly and Co.
o Exhibit 125: Eli Lilly and Co. – Overview
o Exhibit 126: Eli Lilly and Co. – Product / Service
o Exhibit 127: Eli Lilly and Co. – Key news
o Exhibit 128: Eli Lilly and Co. – Key offerings
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 129: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 130: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 131: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 132: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 133: F. Hoffmann La Roche Ltd. – Segment focus
o 12.9 iHealth Labs Inc.
o Exhibit 134: iHealth Labs Inc. – Overview
o Exhibit 135: iHealth Labs Inc. – Product / Service
o Exhibit 136: iHealth Labs Inc. – Key offerings
o 12.10 Insulet Corp.
o Exhibit 137: Insulet Corp. – Overview
o Exhibit 138: Insulet Corp. – Product / Service
o Exhibit 139: Insulet Corp. – Key news
o Exhibit 140: Insulet Corp. – Key offerings
o 12.11 LifeScan IP Holdings LLC
o Exhibit 141: LifeScan IP Holdings LLC – Overview
o Exhibit 142: LifeScan IP Holdings LLC – Product / Service
o Exhibit 143: LifeScan IP Holdings LLC – Key offerings
o 12.12 Medtronic Plc
o Exhibit 144: Medtronic Plc – Overview
o Exhibit 145: Medtronic Plc – Business segments
o Exhibit 146: Medtronic Plc – Key news
o Exhibit 147: Medtronic Plc – Key offerings
o Exhibit 148: Medtronic Plc – Segment focus
o 12.13 Nemaura Medical Inc.
o Exhibit 149: Nemaura Medical Inc. – Overview
o Exhibit 150: Nemaura Medical Inc. – Product / Service
o Exhibit 151: Nemaura Medical Inc. – Key offerings
o 12.14 Nipro Corp.
o Exhibit 152: Nipro Corp. – Overview
o Exhibit 153: Nipro Corp. – Business segments
o Exhibit 154: Nipro Corp. – Key offerings
o Exhibit 155: Nipro Corp. – Segment focus
o 12.15 Nova Biomedical Corp.
o Exhibit 156: Nova Biomedical Corp. – Overview
o Exhibit 157: Nova Biomedical Corp. – Product / Service
o Exhibit 158: Nova Biomedical Corp. – Key offerings
o 12.16 Novo Nordisk AS
o Exhibit 159: Novo Nordisk AS – Overview
o Exhibit 160: Novo Nordisk AS – Business segments
o Exhibit 161: Novo Nordisk AS – Key offerings
o Exhibit 162: Novo Nordisk AS – Segment focus
o 12.17 PHC Holdings Corp.
o Exhibit 163: PHC Holdings Corp. – Overview
o Exhibit 164: PHC Holdings Corp. – Business segments
o Exhibit 165: PHC Holdings Corp. – Key offerings
o Exhibit 166: PHC Holdings Corp. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 167: Inclusions checklist
o Exhibit 168: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 169: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 170: Research methodology
o Exhibit 171: Validation techniques employed for market sizing
o Exhibit 172: Information sources
o 13.5 List of abbreviations
o Exhibit 173: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global diabetes management devices market 2018 – 2022 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2018 – 2022 ($ billion)
Exhibits20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Product – Market share 2023-2028 (%)
Exhibits31: Data Table on Product – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Blood glucose monitoring devices – Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Blood glucose monitoring devices – Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Blood glucose monitoring devices – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Blood glucose monitoring devices – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Insulin delivery systems – Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Insulin delivery systems – Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Insulin delivery systems – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Insulin delivery systems – Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Offline – Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Offline – Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Offline – Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Online – Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Online – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Online – Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Distribution Channel ($ billion)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America – Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe – Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia – Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US – Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US – Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Germany – Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China – Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on China – Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on France – Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on France – Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on France – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on France – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK – Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ billion)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: B.Braun SE – Overview
Exhibits113: B.Braun SE – Business segments
Exhibits114: B.Braun SE – Key news
Exhibits115: B.Braun SE – Key offerings
Exhibits116: B.Braun SE – Segment focus
Exhibits117: Becton Dickinson and Co. – Overview
Exhibits118: Becton Dickinson and Co. – Business segments
Exhibits119: Becton Dickinson and Co. – Key news
Exhibits120: Becton Dickinson and Co. – Key offerings
Exhibits121: Becton Dickinson and Co. – Segment focus
Exhibits122: Bionime Corp. – Overview
Exhibits123: Bionime Corp. – Product / Service
Exhibits124: Bionime Corp. – Key offerings
Exhibits125: Eli Lilly and Co. – Overview
Exhibits126: Eli Lilly and Co. – Product / Service
Exhibits127: Eli Lilly and Co. – Key news
Exhibits128: Eli Lilly and Co. – Key offerings
Exhibits129: F. Hoffmann La Roche Ltd. – Overview
Exhibits130: F. Hoffmann La Roche Ltd. – Business segments
Exhibits131: F. Hoffmann La Roche Ltd. – Key news
Exhibits132: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits133: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits134: iHealth Labs Inc. – Overview
Exhibits135: iHealth Labs Inc. – Product / Service
Exhibits136: iHealth Labs Inc. – Key offerings
Exhibits137: Insulet Corp. – Overview
Exhibits138: Insulet Corp. – Product / Service
Exhibits139: Insulet Corp. – Key news
Exhibits140: Insulet Corp. – Key offerings
Exhibits141: LifeScan IP Holdings LLC – Overview
Exhibits142: LifeScan IP Holdings LLC – Product / Service
Exhibits143: LifeScan IP Holdings LLC – Key offerings
Exhibits144: Medtronic Plc – Overview
Exhibits145: Medtronic Plc – Business segments
Exhibits146: Medtronic Plc – Key news
Exhibits147: Medtronic Plc – Key offerings
Exhibits148: Medtronic Plc – Segment focus
Exhibits149: Nemaura Medical Inc. – Overview
Exhibits150: Nemaura Medical Inc. – Product / Service
Exhibits151: Nemaura Medical Inc. – Key offerings
Exhibits152: Nipro Corp. – Overview
Exhibits153: Nipro Corp. – Business segments
Exhibits154: Nipro Corp. – Key offerings
Exhibits155: Nipro Corp. – Segment focus
Exhibits156: Nova Biomedical Corp. – Overview
Exhibits157: Nova Biomedical Corp. – Product / Service
Exhibits158: Nova Biomedical Corp. – Key offerings
Exhibits159: Novo Nordisk AS – Overview
Exhibits160: Novo Nordisk AS – Business segments
Exhibits161: Novo Nordisk AS – Key offerings
Exhibits162: Novo Nordisk AS – Segment focus
Exhibits163: PHC Holdings Corp. – Overview
Exhibits164: PHC Holdings Corp. – Business segments
Exhibits165: PHC Holdings Corp. – Key offerings
Exhibits166: PHC Holdings Corp. – Segment focus
Exhibits167: Inclusions checklist
Exhibits168: Exclusions checklist
Exhibits169: Currency conversion rates for US$
Exhibits170: Research methodology
Exhibits171: Validation techniques employed for market sizing
Exhibits172: Information sources
Exhibits173: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 糖尿病管理機器の世界市場2024~2028(Global Diabetes Management Devices Market 2024-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆